What is low‑volume plasmapheresis (LVP)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 9, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

What is Low-Volume Plasmapheresis (LVP)?

Low-volume plasmapheresis (LVP) refers to large-volume paracentesis—the therapeutic removal of more than 5 liters of ascitic fluid in a single session from patients with cirrhosis and grade 3 (large) ascites. This is the standard terminology used in hepatology guidelines, where "LVP" is an abbreviation for "large-volume paracentesis," not plasmapheresis in the traditional apheresis sense 1, 2, 3.

Key Procedural Details

LVP is the first-line treatment for patients with large ascites (grade 3) and should be completed in a single session 2, 1. The procedure involves:

  • Volume removed: Typically >5 liters of ascitic fluid, though volumes can reach 8+ liters
  • Albumin replacement: 6-8 g per liter of ascites removed to prevent post-paracentesis circulatory dysfunction (PPCD) 3
  • Timing of albumin: Should be administered at completion of LVP when the total volume removed is known 2

Critical Safety Considerations

Albumin is mandatory when removing >5 liters because alternative plasma expanders (dextran-70, polygeline, saline) are inferior in preventing PPCD and its clinical consequences including renal failure, hyponatremia, hepatic encephalopathy, and death 1. For volumes <5 liters, albumin is still recommended despite lower PPCD risk 2.

Volume Limits and PPCD Risk

The risk of PPCD increases significantly when >8 liters are removed in a single session 3. Recent evidence suggests limiting LVP to <8 liters per session with higher albumin doses (9 g/L) may better preserve renal function and survival, even though PPCD still occurs in 40% of patients 3.

Contraindications

LVP should be avoided in:

  • Disseminated intravascular coagulation
  • Uncooperative patients
  • Abdominal skin infection at puncture sites
  • Severe bowel distension 1

Common Pitfall: Coagulopathy Management

Do NOT routinely give fresh frozen plasma or platelets before LVP, even with INR >1.5 and platelets <50,000/μL 1, 2. Bleeding complications are extremely rare (2/142 procedures in one study), and coagulopathy severity does not correlate with bleeding risk 2. Many centers still unnecessarily transfuse when prothrombin activity <40% or platelets <40,000/μL, but this practice lacks evidence 1.

Post-Procedure Management

After LVP, patients require diuretics to prevent ascites re-accumulation because the procedure does not address the underlying sodium and water retention 1, 2, 1. Use the minimum effective diuretic dose 2.

Important Distinction

The research evidence 4, 5, 6 discussing "low-volume plasmapheresis" or "low-volume plasma exchange" refers to a completely different procedure—therapeutic plasma exchange for acute liver failure where 50% of estimated plasma volume is exchanged per session. This is an apheresis procedure, not paracentesis, and should not be confused with the hepatology term "LVP."

In the context of cirrhosis and ascites management, LVP always means large-volume paracentesis, not plasma exchange.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.